The use of appropriate, inappropriate and no comparators in efficacy trials for European Medicines Agency-approved drugs 2011–2024: a retrospective cohort study

eClinicalMedicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles